ARCHIVES

Large Phase III Trial Seeks Optimal Use Of Tykerb vs. Herceptin In Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

Smoking & Health Contractors Meet

July 11, 1975

AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.

December 14, 2001

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

NCI Unveils Checklist for Omics Studies

February 7, 2013

Electric Blankets May Be Risk Factor In Childhood Cancer

May 18, 1990